Get startedLog in
    Picture of Pharmarise Holdings logo

    2796 — Pharmarise Holdings Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    Consumer DefensivesConservativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Pharmarise Holdings, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

    2020
    May 31st
    2021
    May 31st
    2022
    May 31st
    2023
    May 31st
    2024
    May 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line8191,2021,3221,049143
    Depreciation
    Amortisation
    Non-Cash Items325130214406731
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-801-732-2,131-161671
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities1,5711,9447132,5182,715
    Capital Expenditures-457-552-466-542-619
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-277-524174-161-2,501
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-734-1,076-292-703-3,120
    Financing Cash Flow Items-295-2—-76
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-766-728-1,034-1,0722,771
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash71140-6137432,366